Prestige Consumer Healthcare Inc. (PBH)
Pharmaceutical Preparations · Healthcare · $2.3B
Intrinsic Value (Consensus)
$59.67
Current Price
$47.50
Margin of Safety
+25.6%
25.6% Below Intrinsic Value
Value: $60
Price: $48
Valuation Model Estimates
Current Price: $47.50
DCF (Discounted Cash Flow)
$64.14
Graham Number
$58.38
Earnings Power Value
$37.96
Relative Value (P/E)
$78.20
Dividend Discount Model
Not applicable
—
Consensus Value
$59.67
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
63
Profitability
18/25
Strength
22/25
Valuation
19/25
Growth
4/25
Financial Health Signals
Declining revenue — top line is shrinking
High free cash flow yield (10.6%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $3.91
- EPS (Forward)
- $3.99
- Book Value
- $38.74
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 10.1%
- Debt/Equity
- 53%
- Revenue Growth
- -4.3%
- Earnings Growth
- 2.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance